THERAPEUTIC TRIALS IN CORONARY THROMBOSIS SHOULD MEASURE LEFT VENTRICULAR FUNCTION AS PRIMARY END-POINT OF TREATMENT
- 1 January 1988
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 331 (8577), 104-106
- https://doi.org/10.1016/s0140-6736(88)90295-4
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council
- National Heart Foundation of New Zealand
This publication has 22 references indexed in Scilit:
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Prognosis after recovery from first acute myocardial infarction: Determinants of reinfarction and sudden deathThe American Journal of Cardiology, 1984
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- The stunned myocardium: prolonged, postischemic ventricular dysfunction.Circulation, 1982
- Determinants of Prognosis in Survivors of Myocardial InfarctionNew England Journal of Medicine, 1982
- Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic studyThe American Journal of Cardiology, 1982
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980
- Left ventricular ejection fraction determined by radionuclide ventriculography in early stages of first transmural myocardial infarctionThe American Journal of Cardiology, 1980